Callitas Health Inc (CSE:LILY) (OTCMKTS:WKULF) said Wednesday that it has signed a product development and manufacturing agreement with LifeStyles, the condom company.
Cincinnati-based Callitas will develop sexual-wellness products for LifeStyles, with the first item launching in March. The companies signed a letter of intent in August to develop and supply finished goods for retail sale.
“We’ve been impressed with LifeStyles and its model of business,” Callitas CEO James M. Thompson said in a statement. “Callitas looks forward to our ongoing relationship, one that will be mutually beneficial for both companies’ futures.”
Formed in 2015, Callitas focuses on clinical-stage pharmaceutical development, consumer healthcare and cannabis delivery devices. The company’s ToConceive fertility-enhancing moisturizer is designed to aid in conception.
LifeStyles CEO Jeyan Heper added that the agreement is part of the company’s mission "to spark billions of joyful moments every day.”
Shares of Callitas slipped C$0.01 to C$0.11 in Tuesday’s Canadian trading.
Last week, the company announced that it had signed a letter of intent with NuEthix LLC to manufacture and supply CannaStrip products for retail sale in the US.
Contact Dennis Fitzgerald at [email protected]